May 4, 2024
Loading...
You are here:  Home  >  Health Care & Life Science  -  Page 130
Latest

Santa Barbara doctor writes memoir of Vietnam War

By   /  Friday, June 2nd, 2017  /  Features, Health Care & Life Science, Latest news  /  Comments Off on Santa Barbara doctor writes memoir of Vietnam War

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Pharmaceuticals on path to sustainability

By   /  Friday, May 26th, 2017  /  Green Coast, Health Care & Life Science, Latest news, Op/Eds, Opinion, Technology  /  Comments Off on Pharmaceuticals on path to sustainability

By Valeria Makarova Since the concept of sustainable development was introduced back in the 1980s, corporations from various industries have been dealing with ever-increasing pressure to address stakeholder social needs and their environmental footprints. The traditional “business as usual” model — pursuing the business imperative goal of profit maximization while ignoring negative social and environmental Read More →

Latest

ACA repeal worries Central Coast health care executives

By   /  Friday, May 19th, 2017  /  Health Care & Life Science, middle  /  Comments Off on ACA repeal worries Central Coast health care executives

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Dubroff: End of merger proposal leaves health care future up in the air

By   /  Thursday, May 18th, 2017  /  Columns, Health Care & Life Science, Latest news  /  Comments Off on Dubroff: End of merger proposal leaves health care future up in the air

Henry Dubroff

The debate over the future of health care — in the nation and in the region — comes down to a single question. Is health care a competitive marketplace where price guides choices, or is it a regulated marketplace much like a public utility? That question remains unanswered nationally as Congress grapples with how to Read More →

Latest

Economic summit in Santa Maria focuses on challenges

By   /  Friday, May 12th, 2017  /  Central Coast, Health Care & Life Science, Higher Education, Latest news, Tri-County Economy, Wine & Viticulture  /  Comments Off on Economic summit in Santa Maria focuses on challenges

Sacramento Bee journalist Dan Walters told a crowd of more than 300 people on Friday that liberals need to stop fretting over Donald Trump and realize that most of the problems choking California existed before 2017. “California has a lot of issues that need to be resolved,” Walters said at the UC Santa Barbara North Read More →

Latest

Cottage Health-Sansum Clinic merger proposal withdrawn

By   /  Thursday, May 11th, 2017  /  Health Care & Life Science, Latest news, South Coast, Top Stories, Top Story  /  Comments Off on Cottage Health-Sansum Clinic merger proposal withdrawn

Story updated at 5:20 p.m. May 11: The proposed merger between Cottage Health and Sansum Clinic is dead. Both parties agreed to withdraw the application after nearly four years of awaiting approval from the Federal Trade Commission. “As we approach the four-year mark, we have decided together to withdraw the proposal so we can better Read More →

Latest

Stellar Biotechnologies reports $1.1 million loss for quarter

By   /  Tuesday, May 9th, 2017  /  Earnings, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies, West Ventura County  /  Comments Off on Stellar Biotechnologies reports $1.1 million loss for quarter

Stellar Biotechnologies, based in Port Hueneme, reported drops in both revenues and expenses for the quarter ended March 31. Revenues decreased 81 percent from $330,000 during the same quarter the previous year to $60,000 for the most recent quarter. The immunotherapy developer and manufacturer attributed the decrease to lower sales volume for pre-clinical studies, compared Read More →